WASHINGTON, DC-Pre- and postcontrast chest CTs are done more often by nonradiologists than radiologists.
The use of combined pre- and postcontrast chest CTs among radiologists dramatically decreased when associated with efficiency metrics, but the reduction in use was not as quick among nonradiologists, according to a presentation at ACR 2015, held this week in Washington, DC.
Researchers from the University of Colorado, Denver, The Harvey L. Neiman Health Policy Institute and American College of Radiology in Reston, VA, and The Harvey L. Neiman Health Policy Institute, Atlanta, GA, sought to analyze the trends of utilization of “double scans,” CT studies of the chest, performed both with and without contrast, which have been the focus of hospital outpatient cost- and radiation-reduction metrics by the Center for Medicare and Medicaid Services (CMS) since legislation in 2006.
The researchers identified national claims for CT examinations of the chest (with contrast, without contrast, and both pre- and postcontrast) using Medicare Physician Supplier Procedure Summary Master Files from 2001 through 2012. Changes in the use of double scans were analyzed overall, by provider specialty, and by site of service.
The results show a quicker drop in use among radiologists over nonradiologists:
In the private office setting, double scan rates increased from 2001 through 2007 from 6.9% to 8.0%, and decreased to 5.3% by 2012, representing an overall 23.3% decline.
In all other major sites, declines occurred steadily and at a greater pace:
The researchers concluded that there was a dramatic reduction among radiologists in the use of double scans since imaging efficiency metrics were introduced, but while nonradiologists also decreased use, it was not as quick or as dramatic a decline. “Overall double scan rates remain highest in the private office setting, where declines have been much slower than in all other major sites of service,” they wrote.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.